196 related articles for article (PubMed ID: 34759930)
41. Antitumor activity of human γδ T cells transducted with CD8 and with T-cell receptors of tumor-specific cytotoxic T lymphocytes.
Hanagiri T; Shigematsu Y; Kuroda K; Baba T; Shiota H; Ichiki Y; Nagata Y; Yasuda M; So T; Takenoyama M; Tanaka F
Cancer Sci; 2012 Aug; 103(8):1414-9. PubMed ID: 22621620
[TBL] [Abstract][Full Text] [Related]
42. CD8 alpha beta T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats.
May E; Dorris ML; Satumtira N; Iqbal I; Rehman MI; Lightfoot E; Taurog JD
J Immunol; 2003 Jan; 170(2):1099-105. PubMed ID: 12517979
[TBL] [Abstract][Full Text] [Related]
43. T Cell Receptors for Gene Transfer in Adoptive T Cell Therapy.
Sharma P; Kranz DM
Crit Rev Immunol; 2019; 39(2):105-122. PubMed ID: 31679251
[TBL] [Abstract][Full Text] [Related]
44. Expression of functional CD8alpha Beta heterodimer on rat gamma delta T cells does not correlate with the CDR3 length of the TCR delta chain predicted for MHC class I-restricted antigen recognition.
Straube F; Herrmann T
Eur J Immunol; 2000 Dec; 30(12):3562-8. PubMed ID: 11169397
[TBL] [Abstract][Full Text] [Related]
45. Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.
Roszkowski JJ; Lyons GE; Kast WM; Yee C; Van Besien K; Nishimura MI
Cancer Res; 2005 Feb; 65(4):1570-6. PubMed ID: 15735047
[TBL] [Abstract][Full Text] [Related]
46. Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells.
Dawson NA; Lamarche C; Hoeppli RE; Bergqvist P; Fung VC; McIver E; Huang Q; Gillies J; Speck M; Orban PC; Bush JW; Mojibian M; Levings MK
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30753169
[TBL] [Abstract][Full Text] [Related]
47. CD8αα Expression Marks Terminally Differentiated Human CD8+ T Cells Expanded in Chronic Viral Infection.
Walker LJ; Marrinan E; Muenchhoff M; Ferguson J; Kloverpris H; Cheroutre H; Barnes E; Goulder P; Klenerman P
Front Immunol; 2013; 4():223. PubMed ID: 23964274
[TBL] [Abstract][Full Text] [Related]
48. Identification of HLA-A24-restricted CTL epitope from cancer-testis antigen, NY-ESO-1, and induction of a specific antitumor immune response.
Yamaguchi H; Tanaka F; Ohta M; Inoue H; Mori M
Clin Cancer Res; 2004 Feb; 10(3):890-6. PubMed ID: 14871964
[TBL] [Abstract][Full Text] [Related]
49. T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice.
Dargel C; Bassani-Sternberg M; Hasreiter J; Zani F; Bockmann JH; Thiele F; Bohne F; Wisskirchen K; Wilde S; Sprinzl MF; Schendel DJ; Krackhardt AM; Uckert W; Wohlleber D; Schiemann M; Stemmer K; Heikenwälder M; Busch DH; Richter G; Mann M; Protzer U
Gastroenterology; 2015 Oct; 149(4):1042-52. PubMed ID: 26052074
[TBL] [Abstract][Full Text] [Related]
50. HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.
Boucherma R; Kridane-Miledi H; Bouziat R; Rasmussen M; Gatard T; Langa-Vives F; Lemercier B; Lim A; Bérard M; Benmohamed L; Buus S; Rooke R; Lemonnier FA
J Immunol; 2013 Jul; 191(2):583-93. PubMed ID: 23776170
[TBL] [Abstract][Full Text] [Related]
51. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
52. CD8 T cell tolerance to a tumor-associated self-antigen is reversed by CD4 T cells engineered to express the same T cell receptor.
Ghorashian S; Veliça P; Chua I; McNicol AM; Carpenter B; Holler A; Nicholson E; Ahmadi M; Zech M; Xue SA; Uckert W; Morris E; Chakraverty R; Stauss HJ
J Immunol; 2015 Feb; 194(3):1080-9. PubMed ID: 25539815
[TBL] [Abstract][Full Text] [Related]
53. Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cells.
Giannoni F; Hardee CL; Wherley J; Gschweng E; Senadheera S; Kaufman ML; Chan R; Bahner I; Gersuk V; Wang X; Gjertson D; Baltimore D; Witte ON; Economou JS; Ribas A; Kohn DB
Mol Ther; 2013 May; 21(5):1044-54. PubMed ID: 23380815
[TBL] [Abstract][Full Text] [Related]
54. In Vivo Generation of CAR T Cells Selectively in Human CD4
Agarwal S; Hanauer JDS; Frank AM; Riechert V; Thalheimer FB; Buchholz CJ
Mol Ther; 2020 Aug; 28(8):1783-1794. PubMed ID: 32485137
[TBL] [Abstract][Full Text] [Related]
55. PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations.
Fabian KP; Padget MR; Donahue RN; Solocinski K; Robbins Y; Allen CT; Lee JH; Rabizadeh S; Soon-Shiong P; Schlom J; Hodge JW
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32439799
[TBL] [Abstract][Full Text] [Related]
56. Human adenovirus-specific γ/δ and CD8+ T cells generated by T-cell receptor transfection to treat adenovirus infection after allogeneic stem cell transplantation.
Dörrie J; Krug C; Hofmann C; Müller I; Wellner V; Knippertz I; Schierer S; Thomas S; Zipperer E; Printz D; Fritsch G; Schuler G; Schaft N; Geyeregger R
PLoS One; 2014; 9(10):e109944. PubMed ID: 25289687
[TBL] [Abstract][Full Text] [Related]
57. Canine tissue-associated CD4+CD8α+ double-positive T cells are an activated T cell subpopulation with heterogeneous functional potential.
Rabiger FV; Bismarck D; Protschka M; Köhler G; Moore PF; Büttner M; von Buttlar H; Alber G; Eschke M
PLoS One; 2019; 14(3):e0213597. PubMed ID: 30865691
[TBL] [Abstract][Full Text] [Related]
58. Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice.
Hu Z; Xia J; Fan W; Wargo J; Yang YG
Oncotarget; 2016 Feb; 7(6):6448-59. PubMed ID: 26824989
[TBL] [Abstract][Full Text] [Related]
59. Redirecting αβ T cells against cancer cells by transfer of a broadly tumor-reactive γδT-cell receptor.
Marcu-Malina V; Heijhuurs S; van Buuren M; Hartkamp L; Strand S; Sebestyen Z; Scholten K; Martens A; Kuball J
Blood; 2011 Jul; 118(1):50-9. PubMed ID: 21566093
[TBL] [Abstract][Full Text] [Related]
60. HLA-DPB1*05: 01-restricted WT1332-specific TCR-transduced CD4+ T lymphocytes display a helper activity for WT1-specific CTL induction and a cytotoxicity against leukemia cells.
Lin Y; Fujiki F; Katsuhara A; Oka Y; Tsuboi A; Aoyama N; Tanii S; Nakajima H; Tatsumi N; Morimoto S; Tamanaka T; Tachino S; Hosen N; Nishida S; Oji Y; Kumanogoh A; Sugiyama H
J Immunother; 2013 Apr; 36(3):159-70. PubMed ID: 23502763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
